MedKoo Cat#: 413753 | Name: Iocarmate Meglumine

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Iocarmate Meglumine is iocarmic acid dimeglumine salt.

Chemical Structure

Iocarmate Meglumine
Iocarmate Meglumine
CAS#54605-45-7

Theoretical Analysis

MedKoo Cat#: 413753

Name: Iocarmate Meglumine

CAS#: 54605-45-7

Chemical Formula: C38H54I6N6O18

Exact Mass: 1643.7763

Molecular Weight: 1644.30

Elemental Analysis: C, 27.76; H, 3.31; I, 46.31; N, 5.11; O, 17.51

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Iocarmate Meglumine; LM280; LM-280; LM 280
IUPAC/Chemical Name
Benzoic acid, 3,3'-((1,6-dioxo-1,6-hexanediyl)diimino)bis(2,4,6-triiodo-5-((methylamino)carbonyl)-, compound with 1-deoxy-1-(methylamino)-D-glucitol (1:2)
InChi Key
HOBKVSAGFBYKRQ-VRWDCWMNSA-N
InChi Code
InChI=1S/C24H20I6N4O8.2C7H17NO5/c1-31-21(37)9-13(25)11(23(39)40)17(29)19(15(9)27)33-7(35)5-3-4-6-8(36)34-20-16(28)10(22(38)32-2)14(26)12(18(20)30)24(41)42;2*1-8-2-4(10)6(12)7(13)5(11)3-9/h3-6H2,1-2H3,(H,31,37)(H,32,38)(H,33,35)(H,34,36)(H,39,40)(H,41,42);2*4-13H,2-3H2,1H3/t;2*4-,5+,6+,7+/m.00/s1
SMILES Code
O=C(NC1=C(I)C(C(O)=O)=C(I)C(C(NC)=O)=C1I)CCCCC(NC2=C(I)C(C(O)=O)=C(I)C(C(NC)=O)=C2I)=O.O[C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)CNC.O[C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)CNC
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 1,644.30 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Skalpe IO. Adverse effects of water-soluble contrast media in myelography, cisternography and ventriculography. A review with special reference to metrizamide. Acta Radiol Suppl. 1977;355:359-70. PMID: 400906. 2: Bryan RN, Dauth GW, Gilman S, Hilal SK. Effects of radiographic contrast agents on spinal cord physiology. Invest Radiol. 1981 May-Jun;16(3):234-9. doi: 10.1097/00004424-198105000-00015. PMID: 7263159. 3: Schütte HE. Comparative study: Endografine (diatrizoate), Vasurix polyvidone (acetrizoate), Dimer-X (iocarmate) and Hexabrix (ioxaglate) in hysterosalpingography. Diagn Imaging. 1982;51(6):277-83. PMID: 7173007. 4: Hansen EB, Fahrenkrug A, Praestholm J. Late meningeal effects of myelographic contrast media with special reference to metrizamide. Br J Radiol. 1978 May;51(605):321-7. doi: 10.1259/0007-1285-51-605-321. PMID: 638401. 5: Lipman BT, Haughton VM. Brain beta-endorphin and spinal-cord enkephalin concentrations in experimental arachnoiditis. Invest Radiol. 1987 Mar;22(3):197-200. doi: 10.1097/00004424-198703000-00002. PMID: 2951348. 6: Wang YD, Chen WF. Detecting specific cytotoxic T lymphocytes against SARS- coronavirus with DimerX HLA-A2:Ig fusion protein. Clin Immunol. 2004 Nov;113(2):151-4. doi: 10.1016/j.clim.2004.07.004. PMID: 15451471; PMCID: PMC7106176. 7: Sortland O, Hovind K. Ventriculography with water-soluble contrast media. Acta Radiol Suppl. 1977;355:223-36. PMID: 318145. 8: Bryc S. Jonowe i niejonowe środki cieniujace [Ionic and non-ionic contrast media]. Ann Univ Mariae Curie Sklodowska Med. 1986;41:145-56. Polish. PMID: 3154050. 9: Garancis JC, Haughton VM. Pathogenesis of postmyelographic arachnoiditis. Invest Radiol. 1985 Jan-Feb;20(1):85-9. doi: 10.1097/00004424-198501000-00021. PMID: 3980181. 10: Açikgöz B, Palaoğlu S, Timurkaynak E, Unlü S. Unusual neurological complications of lumbar myelography with dimeglumine iocarmate (Dimer X). Paraplegia. 1986 Nov-Dec;24(6):379-82. doi: 10.1038/sc.1986.56. PMID: 3808749.